- “FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants” (Press release issued by FDA, FDA.gov)
- “J&J Profit Declines on Competition From Generic Drugs” (Bloomberg)
- “Watson gets FDA request on prostate cancer drug” (Forbes)
Read the rest of this entry »
THE LATEST WORD
Top Industry News – July 14, 2009
Posted on July 14th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industry Stories – July 13, 2009
Posted on July 13th, 2009 | by Rxmedyn | No Comments »- “Abraxis BioScience Completes Enrollment of Pivotal Phase III Advanced Lung Cancer Study Evaluating ABRAXANE® Vs. Taxol®” (Press release issued by Abraxis BioScience, BusinessWire)
- “FDA questions data for J&J ovarian cancer drug” (The Associated Press)
- “OSI Pharmaceuticals, Genentech Say Lung Cancer Drug Improves Overall Survival In Late Stage Study” (RTT News)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – July 10, 2009
Posted on July 10th, 2009 | by Rxmedyn | No Comments »- “U.S. to vaccinate millions against swine flu” (San Francisco Chronicle)
- “Johnson & Johnson completes Cougar Biotechnology acquisition” (Press release issued by Johnson & Johnson and Cougar Biotechnology, Trading Markets)
- “Merck & Co shares slip over Zetia/Niaspan trial termination” (Pharma Times)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – July 9, 2009
Posted on July 9th, 2009 | by Rxmedyn | No Comments »- “Merck shares fall on cholesterol study concerns” (Reuters)
- “Sanofi Gets Green Light on Blockbuster Heart Treatment” (Pharmaceutical Executive)
- “FDA Boosts Warnings on Propoxyphene Pain Meds” (Pharmaceutical Executive)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – July 8, 2009
Posted on July 8th, 2009 | by Rxmedyn | No Comments »- “British scientists claim to create human sperm” (The Associated Press)
- “The Amgen D-mab D-bate” (CNBC)
- “AstraZeneca to start Phase IIb study of AZD3480” (Market Watch)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – July 7, 2009
Posted on July 7th, 2009 | by Rxmedyn | No Comments »- “Trinity Biotech’s blood-clot analyzer gets FDA nod” (Reuters)
- “Teva Provides Update on Generic Ortho Tri-Cyclen(R) Lo” (Press release issued by Teva Pharmaceutical Industries, Ltd., Trading Markets)
- “GlaxoSmithKline drug protects against cancer-causing viruses” (Hays Pharma)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – July 6, 2009
Posted on July 6th, 2009 | by Rxmedyn | No Comments »- “FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer” (Press release issued by FDA, FDA.gov)
- “FDA tries to speed access to Protalix Gaucher drug” (Reuters)
- “Sanofi-aventis Unveils Lantus Study Results” (Pharmaceutical Business Review)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – July 2, 2009
Posted on July 2nd, 2009 | by Rxmedyn | No Comments »- “FDA denies approval of King, Acura’s pain drug” (Reuters)
- “J&J to invest $1.5 bln in Elan in Alzheimer’s deal” (Market Watch)
- “WYETH PHARMACEUTICALS and CATALYST BIOSCIENCES announce agreement to develop and commercialize factor VIIa products” (Press release issued by Wyeth Pharmaceuticals and Catalyst Biosciences, WebWire)
Read the rest of this entry »
Posted in Industry Stories
Top Industry Stories – July 1, 2009
Posted on July 1st, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics